Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885544 · ClinicalTrials.gov registry record · NA
Effects of Consuming Red Meat on the Gut Microbiota in Young Adults
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03885544: Completed NA study, sponsored by Purdue University.
NCT03885544 is a NA study that has completed, run by Purdue University. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03885544, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of consuming unprocessed and processed red meat on gut microbiota in young healthy adults in a cross-over, randomized controlled feeding trial.
Primary Outcome
The hypothesis is that compared to consuming a meat-free lacto-ovo vegetarian (LOV) diet, (1) consuming the LOV diet with unprocessed red meat or processed red meat (omnivorous diet) will shift the gut microbiota with greater abundance of the bacteria Lactobacillus and other SCFA producers such as Clostridium XIVa, and no increase of pathogenic bacteria. Compared to consuming a meat-free lacto-ovo vegetarian (LOV) diet, (2) consuming the LOV diet with processed beef and pork (omnivorous diet) wi
Interventions
- OTHER Controlled Lacto-ovo vegetarian diet
- OTHER Controlled Unprocessed red meat diet
- OTHER Controlled processed red meat diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2020-03-23 |
| Phase | NA |
What the finished NCT03885544 record still lists
NCT03885544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Controlled Lacto-ovo vegetarian diet is the first listed.
NCT03885544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03885544 about?
NCT03885544 is a clinical study titled "Effects of Consuming Red Meat on the Gut Microbiota in Young Adults". The purpose of this study is to assess the impact of consuming unprocessed and processed red meat on gut microbiota in young healthy adults in a cross-over, randomized controlled feeding trial.
What is the current status of trial NCT03885544?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2018-01-09. Estimated completion is 2020-03-23.
What interventions are being tested in trial NCT03885544?
The interventions under investigation include: Controlled Lacto-ovo vegetarian diet (OTHER), Controlled Unprocessed red meat diet (OTHER), Controlled processed red meat diet (OTHER).
Who is sponsoring clinical trial NCT03885544?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03885544's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI